Posted on

Food and Drug Administration (FDA) has issued an emergency use authorization for emergency use of convalescent plasma

the staff of the Ridgewood blog

President Trump announced Sunday that the Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for convalescent plasma for emergency use to treat patients sickened by the novel coronavirus as a therapeutic.

Trump, who has been looking to announce progress in fighting the virus, touted the news as a “historic breakthrough” against the “Chine virus” at a White House news conference on Sunday, saying it would “dramatically expand access to this treatment.Not resisting further temptation the President hoped the press had a great time at their convention.

He first focused on the California wildfire situation , and said the Federal government had already deployed 26,000 first responders. On the back to back storms heading for Lousinia and Puerto Rico the President said the Coast Guard and Fema are mobilized .

FDA Commissioner Stephen Hahn said the decision was made in the “independent judgment” of experts and scientists at FDA and that convalescent plasma showed “promising efficacy” as a treatment for coronavirus patients.

“Those scientists have concluded that COVID-19 convalescent plasma is safe and shows promising efficacy, thereby meeting the criteria for an emergency use authorization,” Hahn said at the briefing.

FDA seeks to dramatically increase donations of convalescent plasma by the end of August in the whole-of-America fight against the coronavirus disease 2019 (COVID-19) pandemic.

If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma. Because you fought the infection, your plasma now contains COVID-19 antibodies. These antibodies provided one way for your immune system to fight the virus when you were sick, so your plasma may be able to be used to help others fight off the disease.

Convalescent plasma is the liquid part of blood that is collected from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. COVID-19 patients develop antibodies in the blood against the virus. Antibodies are proteins that might help fight the infection. Convalescent plasma is being investigated for the treatment of COVID-19 because there is no approved treatment for this disease and there is some information that suggests it might help some patients recover from COVID-19.

One thought on “Food and Drug Administration (FDA) has issued an emergency use authorization for emergency use of convalescent plasma

  1. Trump likes it.
    Start the campaign against it.

    GO!

Leave a Reply

Your email address will not be published.